HTTP/2 301 content-type: text/html; charset=UTF-8 content-length: 0 location: https://www.fenwick.com/ date: Sat, 04 Oct 2025 06:35:27 GMT content-security-policy: frame-ancestors 'self'; set-cookie: AWSALBTG=4J5L6YdaD01EMicxvlv+jaRDR6RpRHzsM3QS3JCWJUX6n6QE3CedISFv6xgqaM9KPRdgt6YTw+90eKihrHjgtNox95KIjYMfk6o252VBrIl7elf/4+8b0XKBGF6vk482/01RDWFFKCOXtjw88uASD58QXNN+6YjrKVQ7rF9YXdZC; Expires=Sat, 11 Oct 2025 06:35:27 GMT; Path=/ set-cookie: AWSALBTGCORS=4J5L6YdaD01EMicxvlv+jaRDR6RpRHzsM3QS3JCWJUX6n6QE3CedISFv6xgqaM9KPRdgt6YTw+90eKihrHjgtNox95KIjYMfk6o252VBrIl7elf/4+8b0XKBGF6vk482/01RDWFFKCOXtjw88uASD58QXNN+6YjrKVQ7rF9YXdZC; Expires=Sat, 11 Oct 2025 06:35:27 GMT; Path=/; SameSite=None; Secure set-cookie: AWSALB=mtJ2WfxppEjxbaXICJdtELwayFLXXUeCFgjuPGiZtSJRAO26sWHD99PBXdNAm6HpV6NKxfKTDJihluEdQHHnCVOTd7FTki1IEfkZBTtO64Rl6GANgutvC+9C/cov; Expires=Sat, 11 Oct 2025 06:35:27 GMT; Path=/ set-cookie: AWSALBCORS=mtJ2WfxppEjxbaXICJdtELwayFLXXUeCFgjuPGiZtSJRAO26sWHD99PBXdNAm6HpV6NKxfKTDJihluEdQHHnCVOTd7FTki1IEfkZBTtO64Rl6GANgutvC+9C/cov; Expires=Sat, 11 Oct 2025 06:35:27 GMT; Path=/; SameSite=None; Secure server: Apache x-xss-protection: 1; mode=block x-content-type-options: nosniff x-frame-options: SAMEORIGIN referrer-policy: strict-origin-when-cross-origin strict-transport-security: max-age=63072000; includeSubdomains; preload cache-control: no-cache, no-store, must-revalidate expires: 0 pragma: no-cache x-cache: Miss from cloudfront via: 1.1 8f1942595ba631b82c2ab2e25ec56dc6.cloudfront.net (CloudFront) x-amz-cf-pop: BOM78-P1 alt-svc: h3=":443"; ma=86400 x-amz-cf-id: f7TA3_GmCnGlTsFOoneh84zWLdDgdtjEzojMnYQPZlNsLwUUzIheAA== vary: Origin HTTP/2 200 content-type: text/html; charset=UTF-8 content-length: 13003 date: Fri, 03 Oct 2025 11:42:46 GMT content-encoding: gzip set-cookie: AWSALBTG=IxPhulNUSbrzquJVCrHC1kc0C2Zz6p/UjqWmhC9dHAVKaR/feMp+s6CpmzG06DmRgd89kho570M8LT/bYd06AStTbcWKALKfvekhy6h6K5ZMKMFqcXE6iOsnvMgEfeRvzfmHSfwYhZJuzkgaP8tQYvN3Qfab5P6aoQB6cLDU71T4; Expires=Fri, 10 Oct 2025 11:42:45 GMT; Path=/ set-cookie: AWSALBTGCORS=IxPhulNUSbrzquJVCrHC1kc0C2Zz6p/UjqWmhC9dHAVKaR/feMp+s6CpmzG06DmRgd89kho570M8LT/bYd06AStTbcWKALKfvekhy6h6K5ZMKMFqcXE6iOsnvMgEfeRvzfmHSfwYhZJuzkgaP8tQYvN3Qfab5P6aoQB6cLDU71T4; Expires=Fri, 10 Oct 2025 11:42:45 GMT; Path=/; SameSite=None; Secure set-cookie: AWSALB=gERK7AzoVuaaVIkr/g3GTyvHKqYDQcYULsCpSh1yGdaVhRx5+WPNQm1J+N1HDgTcLB5LsIM0xdvZt48+R/FnmthV+cCtapxLTKHSxgNWl/O7nsEwt6ZH7Ov++gz9; Expires=Fri, 10 Oct 2025 11:42:45 GMT; Path=/ set-cookie: AWSALBCORS=gERK7AzoVuaaVIkr/g3GTyvHKqYDQcYULsCpSh1yGdaVhRx5+WPNQm1J+N1HDgTcLB5LsIM0xdvZt48+R/FnmthV+cCtapxLTKHSxgNWl/O7nsEwt6ZH7Ov++gz9; Expires=Fri, 10 Oct 2025 11:42:45 GMT; Path=/; SameSite=None; Secure set-cookie: 28a6d18546c1aa8f005587ac3a0dc713_identity=8386a39212a95eb9122e4747e20b4695e46df54d6f48f79060e3f57fc9890727a%3A2%3A%7Bi%3A0%3Bs%3A41%3A%2228a6d18546c1aa8f005587ac3a0dc713_identity%22%3Bi%3A1%3Bs%3A168%3A%22%5B1593360%2C%22%5B%5C%22f2mwH6_AD7QzkDnMz39n5oldshn5w7AlrzeU6EeOnMdo1yCB1A2M4foQD2qPgulMZpw_Y22z-1IbSYFLgdOw4FnhaLbtNr3XaN4n%5C%22%2Cnull%2C%5C%228f694609bddc4903b8e8fee50d783cc1%5C%22%5D%22%2C1209600%5D%22%3B%7D; expires=Fri, 17 Oct 2025 11:42:45 GMT; Max-Age=1209599; path=/; secure; HttpOnly server: Apache x-xss-protection: 1; mode=block x-content-type-options: nosniff x-frame-options: SAMEORIGIN referrer-policy: strict-origin-when-cross-origin referrer-policy: no-referrer-when-downgrade strict-transport-security: max-age=63072000; includeSubdomains; preload expires: Thu, 19 Nov 1981 08:52:00 GMT cache-control: no-store pragma: no-cache link: ; rel=dns-prefetch;,; rel=preconnect; crossorigin; link: ; rel='canonical' x-robots-tag: all content-security-policy: frame-ancestors 'self'; vary: Accept-Encoding x-cache: Hit from cloudfront via: 1.1 8f1942595ba631b82c2ab2e25ec56dc6.cloudfront.net (CloudFront) x-amz-cf-pop: BOM78-P1 alt-svc: h3=":443"; ma=86400 x-amz-cf-id: hoPjMVAEIZEklZof02QNYXBkIeST6agK9t5pAyTeKQ3Q-K9mLLdirg== age: 67961 vary: Origin

Purpose-Built for Tech & Life Sciences

Purpose-Built for Tech & Life Sciences

Fenwick Represents Figma in its $1.2B Initial Public Offering

Learn more

Fenwick Represents Figma in its $1.2B Initial Public Offering

Learn more

Fenwick Acts as Lead Transaction Counsel to Wiz in its Pending $32 Billion Acquisition by Google

Wiz

Fenwick Acts as Lead Transaction Counsel to Wiz in its Pending $32 Billion Acquisition by Google

Learn more

Fenwick Launches Boston Office with Leading Life Sciences IP Team

Fenwick Launches Boston Office with Leading Life Sciences IP Team

Learn more

Fenwick Represents CoreWeave in its $1.5B Initial Public Offering, the Second Largest Tech IPO Since 2022

CoreWeave

Fenwick Represents CoreWeave in its $1.5B Initial Public Offering, the Second Largest Tech IPO Since 2022

Learn more

Life Sciences & Tech

Practice Group of the Year

Law360, 2024

Best Place to Work

In New York and the Bay Area

SFBJ & SVBJ, 2023 & Crain's New York, 2023

$15B+

Business counsel to more than 50% of US tech companies valued above $15B

Pitchbook, 2024

Fenwick Represents Shockwave Medical in its $13.1 Billion Acquisition by Johnson & Johnson

Shockwave

Fenwick Represents Shockwave Medical in its $13.1 Billion Acquisition by Johnson & Johnson

Learn more

Fenwick Secures $30.5 Million Jury Verdict for Lashify in Patent Infringement Case

Lashify

Fenwick Secures $30.5 Million Jury Verdict for Lashify in Patent Infringement Case

Learn more

Dedicated to helping technology and life sciences companies thrive at every stage of growth.

Learn More About Fenwick

Trusted by Top-Tier Technology and Life Sciences Companies

People People People

People People People

Make Your Mark at Fenwick To keep pace with our dynamic clients, we are dedicated to building a diverse community of professionals and a culture where talented people thrive. We are proud of the opportunities that set us apart and encourage you to explore all we have to offer. Check Out Fenwick's Current Openings

Insights Insights Insights

Insights Insights Insights

News, Trends, and Insights

Read insightful media interviews, in-depth surveys that guide boardroom discussions, flash reports that synthesize market indicators, and more.

Our Insights

SF & LA Tech Week 2025

September 16, 2025

Events

SF & LA Tech Week 2025

September 16, 2025

News

Fenwick Honored with Multiple Wins at 2025 LMG Life Sciences Americas Awards

September 04, 2025

Publications

Protecting Trade Secrets in the AI Sector: Lessons for AI Companies

September 08, 2025

Experience

Fenwick Represents Databricks in $1B Series K Funding at $100B+ Valuation

September 08, 2025

Subscribe and stay on top of trends and insights

Subscribe